| answer text |
<p>The Department fully understands that maintaining access to vancomycin for the
treatment of Clostridium difficile is vitally important to many people in this country.</p><p>We
are aware that two manufacturers of vancomycin capsules are currently experiencing
supply issues. However, alternative manufacturers have supplies available and there
are sufficient supplies available to continue to meet normal United Kingdom demand.</p><p>We
continue to work closely with industry and partners in the health system to help prevent
shortages and to ensure that the risks to patients are minimised when supply issues
do arise.</p>
|
 |
